These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 795689)

  • 21. Role of somatostatin and its analogues in the pathogenesis and treatment of diabetes mellitus.
    Gerich JE
    Metabolism; 1990 Sep; 39(9 Suppl 2):52-4. PubMed ID: 1976221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Somatostatin--hormone inhibitor (author's transl)].
    Sieradzki J
    Przegl Lek; 1976; 33(3):393-7. PubMed ID: 1273332
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical applications of somatostatin.
    del Pozo E
    Horm Res; 1988; 29(2-3):89-91. PubMed ID: 2900204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of streptozotocin administration on somatostatin content of pancreas and hypothalamus in rats.
    Makino H; Kanatsuka A; Matsushima Y; Yamamoto M; Kumagai A
    Endocrinol Jpn; 1977 Jun; 24(3):295-9. PubMed ID: 144051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
    Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extrahypophyseal effects of somatostatin.
    Efendić S; Lins PE; Uvnäs-Wallensten K
    Ann Clin Res; 1978; 10(3):151-6. PubMed ID: 363038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noradrenergic modulation of human pancreatic growth hormone-releasing factor (hpGHRF1-44)-induced growth hormone release in conscious male rabbits: involvement of endogenous somatostatin.
    Chihara K; Minamitani N; Kaji H; Kodama H; Kita T; Fujita T
    Endocrinology; 1984 Apr; 114(4):1402-6. PubMed ID: 6142818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin: a review of its effects especially in human beings.
    Hansen AP; Lundbaek K
    Diabete Metab; 1976 Dec; 2(4):203-18. PubMed ID: 190058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Somatostatin].
    Tragl KH
    Acta Med Austriaca; 1978; 5(3):80-4. PubMed ID: 377888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroidectomy abolishes pulsatile growth hormone secretion without affecting hypothalamic somatostatin.
    Martin D; Epelbaum J; Bluet-Pajot MT; Prelot M; Kordon C; Durand D
    Neuroendocrinology; 1985 Dec; 41(6):476-81. PubMed ID: 2867482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired suppression of growth hormone release by somatostatin in cultured adenohypophyseal cells of spontaneously diabetic BB/W rats.
    Welsh JB; Szabo M
    Endocrinology; 1988 Nov; 123(5):2230-4. PubMed ID: 2901949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatostatin: physiological and clinical significance.
    Guillemin R; Gerich JE
    Annu Rev Med; 1976; 27():379-88. PubMed ID: 779605
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypothalamic secretion of somatostatin and growth hormone-releasing factor into the hypophysial-portal circulation is reduced in streptozotocin diabetic male rats.
    Plotsky PM
    Neuroendocrinology; 1991 May; 53(5):433-8. PubMed ID: 1678493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between somatostatin and TRH on growth hormone secretion in perifused human growth hormone tumor cells.
    Le Dafniet M; Garnier P; Brandi AM; Bression D; Scherrer H; Racadot J; Peillon F
    Horm Res; 1985; 21(4):235-9. PubMed ID: 2861154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of somatostatin, newcomer from the hypothalamus.
    Guillemin R
    Vopr Biokhim Mozga; 1975; 10():117-21. PubMed ID: 1234665
    [No Abstract]   [Full Text] [Related]  

  • 37. [Somatostatin--chemical structure, function and clinical use].
    Sawano S; Oohashi S
    Nihon Rinsho; 1976; 34(3):620-6. PubMed ID: 819680
    [No Abstract]   [Full Text] [Related]  

  • 38. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice.
    Strowski MZ; Parmar RM; Blake AD; Schaeffer JM
    Endocrinology; 2000 Jan; 141(1):111-7. PubMed ID: 10614629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advances in gastrointestinal peptides: somatostatin].
    Ubilluz R
    Rev Gastroenterol Peru; 1993; 13(3):178-85. PubMed ID: 7910493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypothalamic mechanisms of neurohormone regulation of the endocrine part of the pancreas].
    Kolesnyk IuM; Abramov AV
    Ukr Biokhim Zh (1978); 1993; 65(3):99-104. PubMed ID: 7904782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.